Literature DB >> 32475981

JSH Statement: Tokyo declaration promoting salt reduction by the Japanese Society of Hypertension-the JSH Tokyo declaration.

Takuya Tsuchihashi1, Toshihiko Ishimitsu2, Katsuyuki Ando3, Miho Kusaka4, Atsuhiro Ichihara5, Katsuyuki Miura6, Yuhei Kawano7, Takafumi Ishida8, Hiroo Kumagai9, Atsushi Sakima10, Hiroyuki Takase11, Hitomi Hayabuchi12, Hiroshi Itoh13.   

Abstract

Entities:  

Year:  2020        PMID： 32475981     DOI： 10.1038/s41440-020-0479-0

Source DB:  PubMed          Journal:  Hypertens Res        ISSN： 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  4 in total

Review 1.  Strategies for improving the treatment and control of hypertension in Japan.

Authors:  Atsushi Sakima; Tetsutaro Matayoshi; Hisatomi Arima
Journal:  J Hum Hypertens       Date:  2022-06-03       Impact factor: 3.012

2.  Latest hypertension research to inform clinical practice in Asia.

Authors:  Kazuomi Kario; Masaki Mogi; Satoshi Hoshide
Journal:  Hypertens Res       Date:  2022-04-05       Impact factor: 5.528

3.  Hypertension, cardiovascular disease, and nocturia: a systematic review of the pathophysiological mechanisms.

Authors:  Mitsuru Ohishi; Takuro Kubozono; Koji Higuchi; Yuichi Akasaki
Journal:  Hypertens Res       Date:  2021-03-03       Impact factor: 3.872

Review 4.  Seven-action approaches for the management of hypertension in Asia - The HOPE Asia network.

Authors:  Kazuomi Kario; Yook-Chin Chia; Saulat Siddique; Yuda Turana; Yan Li; Chen-Huan Chen; Jennifer Nailes; Minh Van Huynh; Peera Buranakitjaroen; Hao-Min Cheng; Takeshi Fujiwara; Satoshi Hoshide; Michiaki Nagai; Sungha Park; Jinho Shin; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Apichard Sukonthasarn; Jam Chin Tay; Boon Wee Teo; Kelvin Tsoi; Narsingh Verma; Tzung-Dau Wang; Yuqing Zhang; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-02-16       Impact factor: 3.738
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.